Evidence map›Paper›PMID 42415348›Full record

ArticleNucleus (Austin, Tex.)2026

Elevation of the mechanically-sensitive e protein emerin links nuclear mechanotransduction to tau-induced cytoskeletal remodeling in neurons.

Claira Sohn, Sammy Pardo, Dana Molleur, Satvik R Paduri, Morgan Lambert, Zachary Uttke, Erich J Sohn, Morgan G Thomas, Susan T Weintraub, Bess Frost

Abstract read
In one paragraph

Article in Nucleus (Austin, Tex.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Claira SohnDepartment of Cell Systems and Anatomy, Barshop Institute for Longevity and Aging Studies, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio, San Antonio, TX, USA.
Sammy PardoDepartment of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA.
Dana MolleurDepartment of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA.
Satvik R PaduriDepartment of Molecular Biology, Cell Biology and Biochemistry, Center for Alzheimer's Disease Research, Brown University, Providence, RI, USA.
Morgan LambertDepartment of Molecular Biology, Cell Biology and Biochemistry, Center for Alzheimer's Disease Research, Brown University, Providence, RI, USA.
Zachary UttkeDepartment of Molecular Biology, Cell Biology and Biochemistry, Center for Alzheimer's Disease Research, Brown University, Providence, RI, USA.
Erich J SohnDepartment of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA.
Morgan G ThomasDepartment of Molecular Biology, Cell Biology and Biochemistry, Center for Alzheimer's Disease Research, Brown University, Providence, RI, USA.
Susan T WeintraubDepartment of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA.
Bess FrostDepartment of Molecular Biology, Cell Biology and Biochemistry, Center for Alzheimer's Disease Research, Brown University, Providence, RI, USA.

Funding

Mechanisms of tau- and aging-induced neurological dysfunction: Focus on the nucleusR01AG057896 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FROST, BESS · 2019 to 2023
$2.8M
Investigating mechanisms of neuronal nuclear mechanotransduction in physiological conditions and tauopathyF31NS137774 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SOHN, CLAIRA ROSE · 2024 to 2025
$78k
NIA NIH HHS R01 AG057896NINDS NIH HHS F31 NS137774
6 · The paper itself

Abstract

Neurodegenerative tauopathies, including Alzheimer's disease, are neuropathologically defined by pathological tau deposition. While tau drives neurotoxicity by disrupting cytoskeletal, nucleoskeletal, and genomic architecture, cellular mechanisms mediating tau-induced dysfunction of the cytoskeleton and nucleoskeleton are incompletely understood. Here, we identify proteins with differing abundance in a cellular tauopathy model, iTau. Building upon previous findings that pathogenic tau reduces nuclear tension, we find elevated levels of emerin, a central regulator of nuclear mechanotransduction, in iTau neurons and tau mutant iPSC-derived neurons. Neuronal emerin overexpression drives neurotoxicity, increases filamentous actin (F-actin), and induces nuclear invagination, mimicking cellular phenotypes of tauopathy. Alterations in emerin binding partners reflect its cytosolic relocalization in iTau neurons, suggesting that pathogenic tau may impact nuclear mechanotransduction by altering emerin levels and localization. Overall, we identify emerin as a potential mediator of cytoskeletal and nucleoskeletal remodeling in tauopathy and provide a foundation for future studies of emerin function in neurons.

Indexed as

Cell NucleusCytoskeletonMechanotransduction, CellularMembrane ProteinsNeuronsNuclear Proteinstau ProteinsActinsAnimalsHumansActinsemerinMembrane ProteinsNuclear Proteinstau ProteinsactinAlzheimer’s diseasecytoskeletonemerinMechanotransductionnucleustautauopathy

Identifiers

PMID42415348
PMCPMC13349007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.